PATENT CLAIM ANALYSIS

Application Number: 15937496
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-04
Patent Classification: ["514", "002400"]

Abstract:
Sulfanyl-tetrahydropyran-based compounds, pharmaceutical compositions comprising them, and methods of their use for the treatment of diseases and disorders such as diabetes and obesity are disclosed.

Claim (Index 30):
A method of treating a disease or disorder in a patient, which comprises administering to a patient in need thereof a therapeutically effective amount of a compound of  claim 1 , wherein the disease or disorder is atherosclerosis, cardiovascular disease, diabetes (type 1 or 2), hyperglycemia, hypertension, lipid disorders, obesity, or Syndrome X.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12041860', '12858666', '11862690', '14082786', '13925981']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8235637552313544
- 35 USC 102 Novelty (BERT): 0.6280785714350762
- Combined Prediction Score: 0.8040152368517266
- Mean Citation Score: 501.768728
- Max Citation Score: 581.3088
- Similarity Product: 528.2847787010193

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test